Upcoming Articles of Current Women's Health Reviews

Contents


Characterization of molecular alterations of BRCA1/2: analysis and interpretation guidelines
Daniele Calistri, Valentina Zampiga, Wainer Zoli

Chemoprevention Strategies for High Risk Women
Angela Toss, Federica Sebastiani, Elisabetta Razzaboni, Elisabetta de Matteis, Isabella Marchi, Manuela Proietto, Laura Cortesi

Radiological screening programs for women at high risk of developing breast cancer
Laura Cortesi, Elisabetta De Matteis, Federica Sebastiani, Angela Toss, Isabella Marchi , Rachele Battista, Barbara Canossi, Anna Rita Pecchi, Massimo Federico

Challenges of early onset breast cancer in Sudan: the example of an African context
Khalid Dafaallah Awadelkarim, Ahmed Elhaj, Renato Mariani-Costantini, Elgaylani Abdalla Eltayeb

Breast Cancer: Not Only a “Woman’s” Disease
Rizzolo Piera, Silvestri Valentina, Falchetti Mario, Ottini Laura

Modifiers of risk in BRCA1/2 mutation carriers
Stefano Pepe, Matilde Pensabene, Caterina Condello

Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer: Issues and Clinical Implications
Elisabetta Razzaboni, Giovanni Tazzioli, Alessia Andreotti, Elisabetta De Matteis, Laura Cortesi, Massimo Federico

Identification and characterization of BRCA1and BRCA2 founder mutations
Sidoni T , Cocciolone V, Giannini G, Russo A, Baudi F, Cannita K, Ficorella C, Iacobelli S and Ricevuto E.

What Are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?
Francesca Di Gaudio, Valentina Calò, Laura La Paglia, Loredana Bruno, Florinda Di Piazza, Naomi Margarese, Francesca Paola Guadagna, Girolamo Guarneri, Gaetana Rinaldi, Viviana Bazan and Antonio Russo

How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes?
Di Gaudio F, La Paglia L, Calò V , Bruno L, Di Piazza F, Margarese N, Gulotta E, Cicero G, Bronte G, Rizzo S, Bazan V, A. Russo

Brca1 and Brca2 Molecular Testing in Women With Different Risk of Hereditary Breast Cancer: Cost/Effectiveness and Psychological Implications
Liborio Stuppia

Pharmacological Approaches for BRCA1/2 Related Breast and Ovarian Cancer: Preclinical Studies and Early Clinical Trials
Pierosandro Tagliaferri, Monica Ventura, Iole Cucinotto, Maria Teresa Di Martino, Pierfrancesco Tassone

BRCA Unclassified Variants: How Can be Classified?
Stefania Tommasi, Simona De Summa, Brunella Pilato, Angelo Paradiso